Skip to main content
Clinical Trials/DRKS00025476
DRKS00025476CompletedPhase 2

CoreNAVI - Feasability of a patient navigation programme - CoreNAVI

Charité Campus Virchow-Klinikum0 sites312 target enrollmentStarted: June 4, 2021Last updated:
Conditions

Trial Snapshot

Phase
Phase 2
Status
Completed
Sponsor
Enrollment
312

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional
Allocation
Randomized controlled study
Masking
Open (masking not used)

Eligibility Criteria

Ages
18 Years to one (—)
Sex
All

Inclusion Criteria

  • Confirmed diagnosis of stroke/TIA (ICD-10 Codes: G45.x, I60.x, I61.x, I63.x, I64.x, H34.x, H47.0)
  • Confirmed diagnosis of lung cancer (ICD-10 Codes: C34.1, C34.2, C34.3, C34.8, C34.9, C97)
  • caregiver of a patient with stroke/lung cancer (after consent of the patient or if legal guardianship consists)
  • Age: =18 years
  • living in Berlin or Brandenburg

Exclusion Criteria

  • patients living in nursing care facility
  • patient without caregiver and not able to give informed consent and for which no legal guardianship is in place
  • dementia (inclusion of caregiver may be possible)
  • language barrier (inclusion of caregiver may be possible)

Investigators

Sponsor
Charité Campus Virchow-Klinikum

Similar Trials

CoreNAVI - Feasability of a patient... | Clinical Trial